PTPRN and type 1 diabetes mellitus: While detection of insulin, GAD, IA-2, and ZnT8 antibodies have provided immense benefit in the immunological surveillance of autoimmune diabetes risk and in formal diagnosis following symptom onset, these antigens were all first detected by identification of autoantibodies in T1D patients.